Search results
Order by most recent / most popular / relevance
Results: 1-10 of 108
Teva Canada Innovation v. Attorney General of Canada
- Borden Ladner Gervais LLP
- -
- Canada
- -
- May 8 2013
The Patented Medicine Prices Review Board (the PMPRB) ordered Teva to pay the Crown approximately $2.4 million for selling its product at an
Definition of “innovative drug” does not include variations
- Borden Ladner Gervais LLP
- -
- Canada
- -
- January 23 2013
This is an appeal by Takeda of a decision of the Court, in which the Court upheld the decision of the Minister of Health to refuse to list Takeda’s
Intellectual property weekly abstracts bulletin
- Borden Ladner Gervais LLP
- -
- Canada
- -
- April 1 2013
The Court granted a Prohibition Order to AstraZeneca, preventing Ranbaxy from entering the market with a generic version of ompeprazole until the
Patent refused listing on the Patent Register
- Borden Ladner Gervais LLP
- -
- Canada
- -
- April 30 2012
The Federal Court dismissed a judicial review of a decision of the Minister of Health refusing to list a patent on the Patent Register
Court refuses to reconsider or vary its decision relating to redetermination
- Borden Ladner Gervais LLP
- -
- Canada
- -
- December 7 2010
The Patented Medicines Prices Review Board (PMPRB) made a decision that Teva’s product COPAXONE had been sold at an excessive price
Pleadings for disgorgement of profits and for an accounting of profits in s.8 damages not struck in Ontario court
- Borden Ladner Gervais LLP
- -
- Canada
- -
- August 1 2012
In this case, Apotex has claimed damages in Ontario Court pursuant to, inter alia, section 8 of the NOC Regulations. Lilly brought a motion to strike out parts of Apotex’ statement of claim
Divisional patent application can be filed by applicant not named in original application
- Borden Ladner Gervais LLP
- -
- Canada
- -
- December 15 2010
This case is a judicial review of a decision of the Commissioner of Patents where recognition of a patent application as a divisional application was denied
Lilly v. Apotex
- Borden Ladner Gervais LLP
- -
- Canada
- -
- September 29 2010
Eli Lilly brought suit against Apotex alleging that it infringed eight (8) process patents
Appeal of decision denying interlocutory injunction dismissed
- Borden Ladner Gervais LLP
- -
- Canada
- -
- July 4 2011
This was an appeal of a decision of the Federal Court, refusing an interlocutory motion
Court grants motion to reopen trial and admit new evidence
- Borden Ladner Gervais LLP
- -
- Canada
- -
- April 27 2011
The Federal Court granted leave to reopen the trial and admit new evidence in a matter under reserve, in which no reasons or judgement have issued
Current Search
- Workarea - Patents
- Workarea - Litigation
- Workarea - Healthcare
- Firm Name - Borden Ladner Gervais LLP
Suggested Facets
Author
- Adrian Howard (2)
- Andrea Pitts (1)
- Barbara McIsaac, Q.C. (1)
- Beverley Moore (96)
- Chantal Saunders (96)
- Graeme Boocock, Ph.D. (1)
- Kirsten Crain (2)